AIG
CTXR icon

American International Group’s Citius Pharmaceuticals CTXR Stock Holding History

American International Group’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,652
Closed -$59.5K – 674
2024
Q1 		$59.5K Buy
2,652
+209
+9% +$3.82K ﹤0.01% 2739
2023
Q4 		$46.2K Sell
2,443
-10
-0.4% -$190 ﹤0.01% 2835
2023
Q3 		$42K Buy
2,453
+87
+4% +$2.07K ﹤0.01% 2857
2023
Q2 		$71K Buy
+2,366
New +$77.9K ﹤0.01% 2769
2022
Q2 		– Sell
-2,460
Closed -$110K – 3130
2022
Q1 		$110K Buy
2,460
+46
+2% +$1.82K ﹤0.01% 2557
2021
Q4 		$93K Sell
2,414
-72
-3% -$3.27K ﹤0.01% 2746
2021
Q3 		$126K Sell
2,486
-59
-2% -$2.96K ﹤0.01% 2685
2021
Q2 		$221 Buy
+2,545
New +$153K ﹤0.01% 2449

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's CTXR Position: Q2 2024 in Review

American International Group sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 2,652 shares — an estimated $59.5K sold.

American International Group first reported a position in CTXR in Q2 2021 and held it in 8 quarters. The position peaked at $126K in Q3 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • American International Group reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 2,652 Citius Pharmaceuticals shares in Q2 2024, an estimated $59.5K.
  • American International Group first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • American International Group's Citius Pharmaceuticals position peaked at $126K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.